Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2778-2785

  Choi, Hae Yoon ^a   Kim, Sungeun ^a   Park, Ji Woo ^b   Lee, Nam Seok ^b   Hwang, Soon Young ^a   Huh, Joo Young ^c   Hong, Ho Cheol ^a   Yoo, Hye Jin ^a   Baik, Sei Hyun ^a   Youn, Byung Soo ^b   Mantzoros, Christos S ^c   Choi, Kyung Mook ^a  

^a Korea University College of Medicine   (South Korea)

^b AdipoGen Inc   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADULT; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; FEMALE; FIBRONECTINS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MUSCLE, SKELETAL; OBESITY; POSITRON-EMISSION TOMOGRAPHY; SARCOPENIA;

EID: 84905836995     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1195     Document Type: Article

References (37)

1. Myers J, Kaykha A, George S, Abella J, et al. Fitness versus physical activity patterns in predicting mortality in men. Am J Med. 2004; 117:912-918.
2. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351:2694-2703.
3. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad SciUSA. 2009; 106:20405-20410.
4. Puigserver P, WuZ, ParkCW, Graves R, WrightM, SpiegelmanBM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829-839.
5. Raschke S, Eckardt K, Bjorklund Holven K, Jensen J, Eckel J. Identification and validation of novel contraction-regulated myokines released from primaryhumanskeletal muscle cells.PLoSOne. 2013; 8:e62008.
6. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-β-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
7. Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab. 2013;18:649-659.
8. Zhang Y, Li R, Meng Y, et al. Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling. Diabetes. 2014;63:514-525.
9. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725-1738.
10. Pekkala S, Wiklund PK, Hulmi JJ, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol. 2013;591:5393-5400.
11. Kurdiova T, Balaz M, Vician M, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol. 2014;592:1091-1107.
12. Norheim F, Langleite TM, Hjorth M, et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014;281:739-749.
13. Hecksteden A, Wegmann M, Steffen A, et al. Irisin and exercise training in humans - results from a randomized controlled training trial. BMC Med. 2013;11:235.
14. van Marken Lichtenbelt WD, Vanhommerig JW, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009; 360:1500-1508.
15. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360:1518-1525.
16. Wu J, Boström P, Sparks LM, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150: 366-376.
17. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans.NEngl J Med. 2009; 360:1509-1517.
18. Kim TN, Yang SJ, Yoo HJ, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009;33:885-892.
19. Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010;33:1497-1499.
20. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-896.
21. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437-448.
22. Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:e60563.
23. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769-778.
24. Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature 2012;488:E9-10; discussion E10-11.
25. Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96-101.
26. Enerbäck S. Adipose tissue metabolism in 2012: Adipose tissue plasticity and new therapeutic targets. Nat Rev Endocrinol. 2013; 9:69-70.
27. Cypess AM, White AP, Vernochet C, et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med. 2013;19:635-639.
28. Jespersen NZ, Larsen TJ, Peijs L, et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab. 2013;17:798-805.
29. Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: A renaissance in metabolism? Metabolism. 2013;62:1037-1044.
30. Swick AG, Orena S, O'Connor A. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism. 2013;62:1070-1073.
31. Raschke S, Elsen M, Gassenhuber H, et al. Evidence against a beneficial effect of irisin in humans. PLoS One. 2013;8:e73680.
32. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457-465.
33. Lee DH, Kim YM, Jekal Y, et al. Low levels of physical activity are associated with increased metabolic syndrome risk factors in korean adults. Diabetes Metab J. 2013;37:132-139.
34. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity- correlation with body mass index. Peptides. 2013;39:125-130.
35. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89:465-471.
36. Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899-4907.
37. Boström PA, Fernández-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metabolism. 2014;63:178-180.